Combining Panel-Based Next-Generation Sequencing and Exome Sequencing for Genetic Liver Diseases

Area of Science:

• Genetics
• Medical Diagnostics
• Hepatology

Background:

• Genetic liver diseases are a diverse group of inherited disorders.
• Accurate genetic diagnosis is crucial for effective patient management and counseling.
• Current diagnostic methods may not capture the full spectrum of genetic defects.

Purpose of the Study:

• To evaluate the effectiveness of a combined genetic analysis approach for diagnosing genetic liver diseases.
• To compare the diagnostic yield of different genetic testing tiers: Sanger sequencing, panel-based next-generation sequencing (NGS), and whole-exome sequencing (WES).

Main Methods:

• A tiered genetic testing strategy was applied to 374 patients with suspected genetic liver diseases.
• Tier 1 involved Sanger sequencing of specific genes.
• Tier 2 utilized panel-based NGS, and Tier 3 employed WES.

Main Results:

• The overall diagnostic yield increased with higher tiers of testing, reaching 48.8% with WES.
• Panel-based NGS identified pathogenic variants in 27.8% of patients.
• WES demonstrated a higher detection rate in patients with severe or multi-organ disease.

Conclusions:

• A combined NGS and WES approach is highly efficient for diagnosing diverse genetic liver diseases.
• Tiered genetic testing strategies can optimize diagnostic yield and resource allocation.
• This approach aids in identifying novel genetic defects and understanding disease spectrum.